An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry. 2008 Feb; 65(2):135-44.

View in: PubMed

subject areas

Adult
Alcoholism
Alleles
Amino Acid Substitution
Asparagine
Aspartic Acid
Combined Modality Therapy
Drug Therapy, Combination
Female
Genetic Carrier Screening
Genetic Markers
Genotype
Homozygote
Humans
Liver Function Tests
Male
Middle Aged
Naltrexone
Narcotic Antagonists
Pharmacogenetics
Polymorphism, Genetic
Prognosis
Receptors, Opioid, mu
Taurine
Temperance
Treatment Outcome

authors with profiles

Raymond F Anton